BofA sees more upside in Eli Lilly stock
Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners, even as analysts
Eli Lilly’s first-quarter report gave Wall Street another reason to stay optimistic about one of the market’s biggest pharmaceutical winners, even as analysts
For most of 2026, General Motors (GM) has been a stock that makes investors nervous. From tariff headlines, EV restructuring charges, a war
If you’re a driver who finds stopping in to your local gas station or even Costco or Walmart painful, you have to be
Kevin O’Leary has spent decades telling entrepreneurs on national television precisely what their businesses are worth. Now he is sharing something he rarely
The bill for a quieter, safer financial system is arriving, and it is bigger than most institutions expected. There is a cost building
Well, no one saw that coming. A hike in interest rates may not be imminent but the tea leaves from this week’s Federal
Qualcomm Incorporated (QCOM) added roughly $15 billion in market value as investors embraced a story that reaches beyond any handset rebound. The stock
Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and Goldman Sachs
Mezo Prime is intended for businesses that own Bitcoin but have few ways to use it. Bitcoin kept in an Enclave may be
Celestica (CLS) just erased nearly $10 billion in market value in a single day, sending shares down about 16% after earnings. On the